Changes in blood parameters of patients with laryngeal squamous cell carcinoma during polychemotherapy with cetuximab.
White blood cell
DOI:
10.1200/jco.2017.35.15_suppl.e17579
Publication Date:
2018-09-06T15:47:30Z
AUTHORS (15)
ABSTRACT
e17579 Background: Our purpose was to evaluate changes in blood parameters patients with laryngeal squamous cell carcinoma (LSCC) during polychemotherapy (PCT) cetuximab. Methods: Levels of white cells (WBC), immature granulocytes (IG) and neutrophils (Ne), as well levels C-reactive protein (CRP), lactate dehydrogenase (LDH) creatinine were studied the 20 stage I-III LSCC before therapy cetuximab/cisplatin+5-fluorouracil on days 2, 9 16 therapy. The control group (21 patients) received similar PCT without Treatment assessed using RECIST criteria. Results: Partial response observed (80%) main 5 (23.8%) controls, stabilization - 4 (20%) 12 (57.4%), respectively, progression – (19%) group. Patients treatment effect showed WBC increase by 2 times after every cetuximab injection (days 9, 16) compared initial due Ne IG 2.7 times, respectively. measured 13.40±2.86×10 /L, 13.52±1.88×10 12.25±2.08×10 /L 0.044±0.021×10 0.056±0.015×10 0.060±0.008×10 respectively (p < 0.001). A transient indexes replaced their decrease values, values reference ones end treatment. At same time, we CRP up (7.69±3.28 mg/L 74.75±6.54 umol/L, respectively); LDH did not increase. Stabilization characterized unchanged levels, positive dynamics slow decline level exceeding one (10.0 mg/L) end. Reduction noted controls regardless results which could be explained severity intoxication syndrome, partially disease toxicity. Conclusions: dual reduction indicate minimization myelotoxic general toxic effects combination
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....